DelveInsight’s Metastatic Castration-Resistant Prostate Cancer pipeline report depicts a robust space with 75+ active players working to develop 75+ pipeline therapies for Metastatic ...
Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at ...
Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) were recently ...
A hormone produced in the thyroid gland can play a key role in the development of prostate cancer. This is shown in a new ...
As per DelveInsight estimates, the total prevalent population of prostate cancer in the 7MM was nearly 8,241,000 cases in 2023. These cases are projected to increase during the forecast period, i.e., ...
The PSMA-targeted therapy market is expected to grow strongly, fueled by higher prostate cancer diagnosis rates, improved awareness of PSMA-based treatments, and an expanding clinical trial landscape ...
The PSMA-targeted therapy market is expected to grow strongly, fueled by higher prostate cancer diagnosis rates, improved awareness of PSMA-based treatments, and an expanding clinical trial ...
14don MSN
Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
Blue Earth Therapeutics today announced that the first patients in the UK have been administered with the investigational ...
Kanpur: Indian Institute of Technology Kanpur's Prof Bushra Ateeq of department of Biological Sciences and Bioengineering and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback